Inhibition of HIV-1 replication by RNA-based strategies
The major etiologic agent of the acquired immunodeficiency syndrome (AIDS) is the human immunodeficiency virus type 1 (HIV-1), which belongs to the family of human retroviruses. This pandemic infection affects millions of people worldwide. The most efficient current treatment regimen for HIV-infecte...
| Authors: | , , |
|---|---|
| Format: | article |
| Status: | Versión enviada para evaluación y publicación |
| Publication Date: | 1988 |
| Country: | España |
| Institution: | Consejo Superior de Investigaciones Científicas (CSIC) |
| Repository: | DIGITAL.CSIC. Repositorio Institucional del CSIC |
| OAI Identifier: | oai:digital.csic.es:10261/143221 |
| Online Access: | http://hdl.handle.net/10261/143221 |
| Access Level: | Open access |
| Keyword: | HIV-1 RNA therapies ribozymes Antisense RNAs RNA aptamers small interference RNAs |
| id |
ES_5ad9d1db2bfb5403dbb4916099e88d4b |
|---|---|
| oai_identifier_str |
oai:digital.csic.es:10261/143221 |
| network_acronym_str |
ES |
| network_name_str |
España |
| repository_id_str |
|
| spelling |
Inhibition of HIV-1 replication by RNA-based strategiesReyes-Darias, José AntonioSánchez-Luque, Francisco J.Berzal-Herranz, AlfredoHIV-1RNA therapiesribozymesAntisense RNAsRNA aptamerssmall interference RNAsThe major etiologic agent of the acquired immunodeficiency syndrome (AIDS) is the human immunodeficiency virus type 1 (HIV-1), which belongs to the family of human retroviruses. This pandemic infection affects millions of people worldwide. The most efficient current treatment regimen for HIV-infected individuals combines two or more drugs targeting different HIV-specific enzymes. However, the emergence of multiple drug-resistant HIV-1 strains and the side effects of drug-based therapies make alternative approaches for the treatment of HIV infection and AIDS necessary. RNA-based antiviral approaches are among the most promising for developing long-term anti-HIV therapies. Anti-HIV-1 RNA-based strategies include ribozymes, antisense RNAs, RNA aptamers, RNA decoys, external guide sequences (EGS) for site-specific cleavage of RNA molecules with human ribonuclease P (RNase P), modified small nuclear RNA (RNAu) and small interfering RNAs (siRNAs). This review describes the main features and functions of viral and cellular targets as well as the different classes of RNA molecules that have been explored in developing therapeutic strategies against HIV infection. Many RNA-based strategies are already being tested in human clinical trials or are currently being developed for future trials.This work was supported by grants 34672/05 from FIPSE and BIO-265 from the Junta de Andalucía to AB-HPeer reviewedBentham Science PublishersConsejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72]201720171988info:eu-repo/semantics/articlehttp://purl.org/coar/resource_type/c_6501Preprintinfo:eu-repo/semantics/submittedVersionhttp://hdl.handle.net/10261/143221reponame:DIGITAL.CSIC. Repositorio Institucional del CSICinstname:Consejo Superior de Investigaciones Científicas (CSIC)Ingléshttp://www.eurekaselect.com/92944/article#Síinfo:eu-repo/semantics/openAccessoai:digital.csic.es:10261/1432212026-05-22T06:33:51Z |
| dc.title.none.fl_str_mv |
Inhibition of HIV-1 replication by RNA-based strategies |
| title |
Inhibition of HIV-1 replication by RNA-based strategies |
| spellingShingle |
Inhibition of HIV-1 replication by RNA-based strategies Reyes-Darias, José Antonio HIV-1 RNA therapies ribozymes Antisense RNAs RNA aptamers small interference RNAs |
| title_short |
Inhibition of HIV-1 replication by RNA-based strategies |
| title_full |
Inhibition of HIV-1 replication by RNA-based strategies |
| title_fullStr |
Inhibition of HIV-1 replication by RNA-based strategies |
| title_full_unstemmed |
Inhibition of HIV-1 replication by RNA-based strategies |
| title_sort |
Inhibition of HIV-1 replication by RNA-based strategies |
| dc.creator.none.fl_str_mv |
Reyes-Darias, José Antonio Sánchez-Luque, Francisco J. Berzal-Herranz, Alfredo |
| author |
Reyes-Darias, José Antonio |
| author_facet |
Reyes-Darias, José Antonio Sánchez-Luque, Francisco J. Berzal-Herranz, Alfredo |
| author_role |
author |
| author2 |
Sánchez-Luque, Francisco J. Berzal-Herranz, Alfredo |
| author2_role |
author author |
| dc.contributor.none.fl_str_mv |
Consejo Superior de Investigaciones Científicas [https://ror.org/02gfc7t72] |
| dc.subject.none.fl_str_mv |
HIV-1 RNA therapies ribozymes Antisense RNAs RNA aptamers small interference RNAs |
| topic |
HIV-1 RNA therapies ribozymes Antisense RNAs RNA aptamers small interference RNAs |
| description |
The major etiologic agent of the acquired immunodeficiency syndrome (AIDS) is the human immunodeficiency virus type 1 (HIV-1), which belongs to the family of human retroviruses. This pandemic infection affects millions of people worldwide. The most efficient current treatment regimen for HIV-infected individuals combines two or more drugs targeting different HIV-specific enzymes. However, the emergence of multiple drug-resistant HIV-1 strains and the side effects of drug-based therapies make alternative approaches for the treatment of HIV infection and AIDS necessary. RNA-based antiviral approaches are among the most promising for developing long-term anti-HIV therapies. Anti-HIV-1 RNA-based strategies include ribozymes, antisense RNAs, RNA aptamers, RNA decoys, external guide sequences (EGS) for site-specific cleavage of RNA molecules with human ribonuclease P (RNase P), modified small nuclear RNA (RNAu) and small interfering RNAs (siRNAs). This review describes the main features and functions of viral and cellular targets as well as the different classes of RNA molecules that have been explored in developing therapeutic strategies against HIV infection. Many RNA-based strategies are already being tested in human clinical trials or are currently being developed for future trials. |
| publishDate |
1988 |
| dc.date.none.fl_str_mv |
1988 2017 2017 |
| dc.type.none.fl_str_mv |
info:eu-repo/semantics/article http://purl.org/coar/resource_type/c_6501 Preprint info:eu-repo/semantics/submittedVersion |
| format |
article |
| status_str |
submittedVersion |
| dc.identifier.none.fl_str_mv |
http://hdl.handle.net/10261/143221 |
| url |
http://hdl.handle.net/10261/143221 |
| dc.language.none.fl_str_mv |
Inglés |
| language_invalid_str_mv |
Inglés |
| dc.relation.none.fl_str_mv |
http://www.eurekaselect.com/92944/article# Sí |
| dc.rights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
Bentham Science Publishers |
| publisher.none.fl_str_mv |
Bentham Science Publishers |
| dc.source.none.fl_str_mv |
reponame:DIGITAL.CSIC. Repositorio Institucional del CSIC instname:Consejo Superior de Investigaciones Científicas (CSIC) |
| instname_str |
Consejo Superior de Investigaciones Científicas (CSIC) |
| reponame_str |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| collection |
DIGITAL.CSIC. Repositorio Institucional del CSIC |
| repository.name.fl_str_mv |
|
| repository.mail.fl_str_mv |
|
| _version_ |
1869408750244200448 |
| score |
15.812455 |